Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dishman Pharmaceuticals & Chemicals

Dishman Pharmaceuticals & Chemicals

BSE: 532526|NSE: DISHMAN|ISIN: INE353G01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 24, 15:43
331.65
3 (0.91%)
VOLUME 149,954
LIVE
NSE
Apr 24, 15:48
331.40
3.6 (1.1%)
VOLUME 641,843
News on Dishman Pharmaceuticals & Chemicals
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Monday could be a make or break for Nifty; 5 stock which could give upto 14% return

10.49 am | 14 Apr 2017 |  Source: Moneycontrol.com

Recent outperformance of BankNifty has restricted the decline in the markets. It certainly holds the key in deciding the next leg of the journey of th...

Buy STC, Ceat, Dishman Pharma: Ashwani Gujral 

2.44 pm | 13 Apr 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com suggests buying STC, Ceat and Dishman Pharma....

Here are fundamental trading ideas from Anand Tandon 

2.38 pm | 05 Apr 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18’s Prashant Nair and Ekta Batra, Anand Tandon, a Market Expert shared his readings and outlook on market and specific st...

Motilal Oswal buys 8.48 lakh shares of Dishman Pharma

8.35 am | 30 Mar 2017 |  Source: Moneycontrol.com

On March 29, 2017 Motilal Oswal Asset Management Co - Invest In (PMS) bought 8,48,024 shares of Dishman Pharmaceuticals....

Dishman Pharma rises 20% on USFDA approval for cancer drug 

9.29 am | 28 Mar 2017 |  Source: Moneycontrol.com

The company has received United States Food and Drug Administration (USFDA) approval for cancer drug Zejula Capsules, for Tesaro Inc....

Dishman Pharma: Outcome of board meeting

10.01 pm | 17 Mar 2017 |  Source: Moneycontrol.com

A Meeting of the Board of Directors of the Company was held on today i.e. on 17th day of March, 2017....

Buy Dishman Pharma; target of Rs 285: Systematix

2.48 pm | 17 Feb 2017 |  Source: Moneycontrol.com

Systematix is bullish on Dishman Pharma has recommended buy rating on the stock with a target price of Rs 285 in its research report dated February 14...

Dishman Pharma Q3 net profit up 13% at Rs 50.68 cr

4.44 pm | 13 Feb 2017 |  Source: PTI

Dishman Pharmaceuticals and Chemicals today reported a 13.22 percent rise in its consolidated net profit to Rs 50.68 crore for the quarter ended Decem...

Dishman Pharma Q2 net profit surges near two-fold to Rs 55 cr

2.58 pm | 27 Oct 2016 |  Source: PTI

The company had posted a net profit after taxes, minority interest and share of profit/(loss) of the associates of Rs 27.73 crore for the correspondin...

1 2
Quick Links for Dishman Pharmaceuticals & Chemicals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.